Screening mammography rate and predictors following treatment for colorectal cancer
Screening mammography rate and predictors following treatment for colorectal cancer
复制标题
DOI：
10.1007/s11764-009-0080-7
复制
发表时间：
2009-03-01
影响因子：
3.7
通讯作者：
Virnig, Beth A.
中科院分区：
文献类型：
--
作者：
McBean, A. Marshall;Yu, Xinhua;Virnig, Beth A.
简介 结直肠癌幸存者仍然面临患乳腺癌的风险。因此，确定乳腺癌筛查率是否因结直肠癌的诊断和治疗而降低非常重要。方法将 7,666 名 67-79 岁 0-III 期结直肠癌幸存者的乳房 X 光检查率与 36,433 名年龄、种族/族裔、SEER 区域匹配的女性进行比较，并控制诊断前乳房 X 光检查、分期、化疗、收入、合并症、教学医院的治疗、就诊医生和妇科医生的次数。 结果 在诊断后的头 2 年里，幸存者的存活率 (49.7/100) 比对照组 (47.6/100) 高出 4.2%，p
Introduction Colorectal cancer survivors remain at risk for breast cancer. Thus, it is important to determine if screening mammography rates are reduced by the diagnosis and treatment of incident colorectal cancer.Methods Mammography rates among 7,666 67-79 year-old stage 0-III colorectal cancer survivors were compared with rates among 36,433 age-, race/ethnicity-, SEER area-matched women controlling for pre-diagnosis mammography, stage, chemotherapy, income, co-morbidities, treatment in teaching hospital, number of physician visits, and gynecologist visits.Results In the first 2 years after diagnosis, the survivors' rate (49.7/100) was 4.2% higher than the controls' (47.6/100), p